NEW YORK (GenomeWeb) – Cold Spring Harbor Laboratory today announced that it has selected Hairpin Technologies as a commercial distributor for the research use of its proprietary short hairpin RNA (shRNA) technologies.
Hairpin will now serve as CSHL's exclusive agent for negotiating and executing new license agreements with licensees of US and international patents covering the technology. Specific terms of the arrangement were not disclosed.
The shRNA technologies relate to RNAi-based gene-silencing molecules developed by CSHL's Gregory Hannon. They are already commercially available from certain authorized distributors holding non-exclusive rights to make, market, and sell shRNA reagents including Cellecta, GE Healthcare, Mirimus, and TransOMIC.